Morgan Stanley’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $281M | Buy |
2,716,044
+422,893
| +18% | +$47.9M | 0.02% | 773 |
|
|
2025
Q4 | $231M | Sell |
2,293,151
-902,664
| -28% | -$98M | 0.01% | 864 |
|
|
2025
Q3 | $394M | Buy |
3,195,815
+493,624
| +18% | +$61.3M | 0.02% | 611 |
|
|
2025
Q2 | $324M | Buy |
2,702,191
+45,465
| +2% | +$6.07M | 0.02% | 650 |
|
|
2025
Q1 | $391M | Buy |
2,656,726
+43,823
| +2% | +$6.69M | 0.03% | 563 |
|
|
2024
Q4 | $424M | Buy |
2,612,903
+103,807
| +4% | +$17M | 0.03% | 533 |
|
|
2024
Q3 | $409M | Buy |
2,509,096
+58,438
| +2% | +$8.66M | 0.03% | 549 |
|
|
2024
Q2 | $334M | Sell |
2,450,658
-3,601
| -0.1% | -$500K | 0.03% | 591 |
|
|
2024
Q1 | $376M | Sell |
2,454,259
-2,237,739
| -48% | -$334M | 0.03% | 546 |
|
|
2023
Q4 | $669M | Buy |
4,691,998
+2,953,070
| +170% | +$394M | 0.03% | 560 |
|
|
2023
Q3 | $228M | Buy |
1,738,928
+30,902
| +2% | +$4.7M | 0.02% | 641 |
|
|
2023
Q2 | $272M | Sell |
1,708,026
-18,578
| -1% | -$3M | 0.03% | 597 |
|
|
2023
Q1 | $273M | Sell |
1,726,604
-73,972
| -4% | -$11.1M | 0.03% | 589 |
|
|
2022
Q4 | $253M | Buy |
1,800,576
+119,164
| +7% | +$16.9M | 0.03% | 587 |
|
|
2022
Q3 | $216M | Sell |
1,681,412
-208,038
| -11% | -$30M | 0.03% | 544 |
|
|
2022
Q2 | $266M | Buy |
1,889,450
+676,990
| +56% | +$96.7M | 0.03% | 485 |
|
|
2022
Q1 | $169M | Sell |
1,212,460
-83,716
| -6% | -$12.8M | 0.02% | 592 |
|
|
2021
Q4 | $226M | Sell |
1,296,176
-698,361
| -35% | -$116M | 0.03% | 518 |
|
|
2021
Q3 | $330M | Buy |
1,994,537
+216,687
| +12% | +$37.3M | 0.04% | 367 |
|
|
2021
Q2 | $320M | Buy |
1,777,850
+917,080
| +107% | +$167M | 0.04% | 383 |
|
|
2021
Q1 | $166M | Buy |
860,770
+76,021
| +10% | +$14.6M | 0.02% | 547 |
|
|
2020
Q4 | $158M | Sell |
784,749
-16,424
| -2% | -$3.4M | 0.02% | 544 |
|
|
2020
Q3 | $168M | Sell |
801,173
-52,050
| -6% | -$11.6M | 0.03% | 439 |
|
|
2020
Q2 | $187M | Buy |
853,223
+119,920
| +16% | +$24M | 0.04% | 372 |
|
|
2020
Q1 | $127M | Buy |
733,303
+56,933
| +8% | +$9.41M | 0.03% | 430 |
|
|
2019
Q4 | $104M | Sell |
676,370
-125,546
| -16% | -$18.8M | 0.02% | 589 |
|
|
2019
Q3 | $122M | Sell |
801,916
-1,391,012
| -63% | -$220M | 0.03% | 491 |
|
|
2019
Q2 | $336M | Buy |
2,192,928
+165,160
| +8% | +$25.2M | 0.09% | 229 |
|
|
2019
Q1 | $325M | Buy |
2,027,768
+102,537
| +5% | +$15.9M | 0.09% | 230 |
|
|
2018
Q4 | $297M | Sell |
1,925,231
-1,138,582
| -37% | -$177M | 0.09% | 231 |
|
|
2018
Q3 | $461M | Buy |
3,063,813
+1,962,433
| +178% | +$279M | 0.12% | 181 |
|
|
2018
Q2 | $149M | Buy |
1,101,380
+337,621
| +44% | +$41.7M | 0.04% | 425 |
|
|
2018
Q1 | $102M | Sell |
763,759
-429,236
| -36% | -$57.7M | 0.03% | 587 |
|
|
2017
Q4 | $177M | Sell |
1,192,995
-60,153
| -5% | -$8.18M | 0.05% | 390 |
|
|
2017
Q3 | $165M | Buy |
1,253,148
+87,408
| +7% | +$11.7M | 0.05% | 373 |
|
|
2017
Q2 | $155M | Buy |
1,165,740
+169,371
| +17% | +$22.9M | 0.05% | 399 |
|
|
2017
Q1 | $134M | Buy |
996,369
+241,210
| +32% | +$31.2M | 0.04% | 449 |
|
|
2016
Q4 | $90.6M | Sell |
755,159
-500,419
| -40% | -$59M | 0.03% | 581 |
|
|
2016
Q3 | $157M | Buy |
1,255,578
+212,103
| +20% | +$27.8M | 0.05% | 379 |
|
|
2016
Q2 | $144M | Buy |
1,043,475
+16,123
| +2% | +$2.09M | 0.05% | 397 |
|
|
2016
Q1 | $130M | Buy |
1,027,352
+11,127
| +1% | +$1.41M | 0.05% | 399 |
|
|
2015
Q4 | $129M | Buy |
1,016,225
+12,516
| +1% | +$1.55M | 0.05% | 402 |
|
|
2015
Q3 | $116M | Buy |
1,003,709
+128,715
| +15% | +$14.4M | 0.04% | 422 |
|
|
2015
Q2 | $91M | Buy |
874,994
+3,539
| +0.4% | +$382K | 0.03% | 550 |
|
|
2015
Q1 | $96.2M | Sell |
871,455
-183,775
| -17% | -$20M | 0.04% | 515 |
|
|
2014
Q4 | $110M | Buy |
1,055,230
+393,131
| +59% | +$39.3M | 0.04% | 474 |
|
|
2014
Q3 | $63.6M | Sell |
662,099
-33,271
| -5% | -$3.01M | 0.02% | 712 |
|
|
2014
Q2 | $63.6M | Sell |
695,370
-142,233
| -17% | -$12.7M | 0.02% | 682 |
|
|
2014
Q1 | $73.7M | Sell |
837,603
-12,904
| -2% | -$1.13M | 0.03% | 579 |
|
|
2013
Q4 | $78.9M | Sell |
850,507
-134,952
| -14% | -$12.2M | 0.03% | 536 |
|
|
2013
Q3 | $80.5M | Buy |
985,459
+190,453
| +24% | +$16.1M | 0.04% | 486 |
|
|
2013
Q2 | $66.1M | Buy |
+795,006
| New | +$68.4M | 0.03% | 533 |
|
Other funds holding CLX
VCM
VPM
DAM
Morgan Stanley's CLX Position: Q1 2026 in Review
Morgan Stanley increased its Clorox (CLX) stake by 18% in Q1 2026, buying an estimated $47.9M and bringing the position to 2,716,044 shares worth $281M. The position accounts for 0.02% of the portfolio, ranked #773.
Morgan Stanley first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $669M in Q4 2023. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.
- Morgan Stanley held 2,716,044 shares of Clorox worth $281M as of Q1 2026.
- Morgan Stanley bought 422,893 Clorox shares in Q1 2026, an estimated $47.9M.
- Clorox made up 0.02% of Morgan Stanley's portfolio in Q1 2026, its #773 holding.
- Morgan Stanley first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Clorox position peaked at $669M in Q4 2023.
- 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.